- Published on
Ophthalmology – Cavernous Sinus Thrombosis (CST)
Cavernous sinus thrombosis (CST) is a rare but potentially life-threatening condition characterized by the formation of a thrombus within the cavernous sinus. It may be septic, aseptic, or vascular in origin. Septic CST results from the spread of infection, most commonly from the paranasal sinuses, dental infections, facial skin infections, or middle ear infections. Aseptic CST occurs in the setting of hypercoagulable states, trauma, or surgery, while vascular causes are often related to carotid–cavernous fistulas. Due to the valveless venous system of the face and orbit, infections can spread retrograde into the cavernous sinus, making this condition particularly dangerous.
Although CST is rare, it carries significant morbidity and mortality. Septic CST was once universally fatal, but with modern treatment, mortality has decreased to approximately 30%. Risk factors vary depending on the etiology. Septic CST often occurs in otherwise healthy individuals with recent head or neck infections, whereas aseptic CST is associated with hypercoagulable states such as antiphospholipid syndrome, malignancy, pregnancy, or inherited thrombophilias. Additional risk factors include diabetes, immunosuppression, trauma, and sinus disease.
The pathophysiology involves obstruction of venous drainage within the cavernous sinus, leading to orbital congestion and impaired cranial nerve function. The cranial nerves that traverse the cavernous sinus—III, IV, V1, V2, and VI—may be affected, resulting in ophthalmoplegia, facial sensory deficits, and visual disturbances. Impaired venous outflow also leads to proptosis, chemosis, and increased intraocular pressure, while severe cases may extend intracranially, causing meningitis, abscess formation, or stroke.
Patients typically present with headache, which is the most common symptom, along with fever in septic cases. A history of sinusitis, dental infection, facial infection, or recent trauma may be elicited. Ocular symptoms include diplopia, decreased vision, and eye pain. On examination, findings often include proptosis, chemosis, eyelid edema, and ophthalmoplegia. Cranial nerve palsies are common, particularly involving the abducens nerve. Trigeminal nerve involvement, especially sensory loss in the V1 or V2 distribution, is an important distinguishing feature from orbital cellulitis. Bilateral orbital involvement is also highly suggestive of CST rather than simple orbital cellulitis.
Diagnosis is primarily clinical, supported by laboratory and imaging studies. Laboratory evaluation includes complete blood count, coagulation profile, blood cultures, and cultures of any suspected infection source. Imaging with CT scan is usually the first step and may show indirect signs such as enlargement of the superior ophthalmic vein or abnormal filling of the cavernous sinus. MRI provides greater sensitivity for detecting thrombus and associated soft tissue changes. However, imaging may not always detect early CST, and a high index of clinical suspicion is essential.
Management of CST is an emergency and requires immediate hospitalization. Septic CST is treated with broad-spectrum intravenous antibiotics, typically a combination of a third-generation cephalosporin and vancomycin, with antifungal therapy added if indicated. Aseptic CST is managed with anticoagulation, while cases related to fistulas may require angiography and endovascular intervention. Surgical drainage of the primary infectious source, such as sinus or dental abscess, is often necessary. The use of anticoagulation in septic CST remains controversial but may be considered in selected cases. Corticosteroids are reserved for specific indications such as pituitary insufficiency.
Close inpatient monitoring is critical, often in an intensive care setting for severe cases. Follow-up care depends on the underlying cause and includes prolonged antibiotic therapy, monitoring for recurrence, and management of any persistent neurologic deficits. Patients with hypercoagulable states may require long-term anticoagulation.
The prognosis of CST depends on its cause and the timeliness of treatment. Septic CST carries a guarded prognosis, with significant mortality and a high rate of long-term neurologic sequelae among survivors. In contrast, CST associated with fistulas generally has a better outcome if treated appropriately. Complications include permanent vision loss, cranial nerve deficits, intracranial infections such as meningitis or encephalitis, hemorrhagic stroke, and death.
Early recognition and prompt treatment are essential to improving outcomes. Key clinical clues include bilateral orbital signs, cranial nerve involvement, and a history of infection or hypercoagulable risk factors. Even in the presence of inconclusive imaging, CST should be strongly considered when clinical suspicion is high, as delays in treatment can lead to devastating consequences.
Cavernous sinus thrombosis (CST) is a rare but potentially life-threatening condition characterized by the formation of a thrombus within the cavernous sinus. It may be septic, aseptic, or vascular in origin. Septic CST results from the spread of infection, most commonly from the paranasal sinuses, dental infections, facial skin infections, or middle ear infections. Aseptic CST occurs in the setting of hypercoagulable states, trauma, or surgery, while vascular causes are often related to carotid–cavernous fistulas. Due to the valveless venous system of the face and orbit, infections can spread retrograde into the cavernous sinus, making this condition particularly dangerous.
Although CST is rare, it carries significant morbidity and mortality. Septic CST was once universally fatal, but with modern treatment, mortality has decreased to approximately 30%. Risk factors vary depending on the etiology. Septic CST often occurs in otherwise healthy individuals with recent head or neck infections, whereas aseptic CST is associated with hypercoagulable states such as antiphospholipid syndrome, malignancy, pregnancy, or inherited thrombophilias. Additional risk factors include diabetes, immunosuppression, trauma, and sinus disease.
The pathophysiology involves obstruction of venous drainage within the cavernous sinus, leading to orbital congestion and impaired cranial nerve function. The cranial nerves that traverse the cavernous sinus—III, IV, V1, V2, and VI—may be affected, resulting in ophthalmoplegia, facial sensory deficits, and visual disturbances. Impaired venous outflow also leads to proptosis, chemosis, and increased intraocular pressure, while severe cases may extend intracranially, causing meningitis, abscess formation, or stroke.
Patients typically present with headache, which is the most common symptom, along with fever in septic cases. A history of sinusitis, dental infection, facial infection, or recent trauma may be elicited. Ocular symptoms include diplopia, decreased vision, and eye pain. On examination, findings often include proptosis, chemosis, eyelid edema, and ophthalmoplegia. Cranial nerve palsies are common, particularly involving the abducens nerve. Trigeminal nerve involvement, especially sensory loss in the V1 or V2 distribution, is an important distinguishing feature from orbital cellulitis. Bilateral orbital involvement is also highly suggestive of CST rather than simple orbital cellulitis.
Diagnosis is primarily clinical, supported by laboratory and imaging studies. Laboratory evaluation includes complete blood count, coagulation profile, blood cultures, and cultures of any suspected infection source. Imaging with CT scan is usually the first step and may show indirect signs such as enlargement of the superior ophthalmic vein or abnormal filling of the cavernous sinus. MRI provides greater sensitivity for detecting thrombus and associated soft tissue changes. However, imaging may not always detect early CST, and a high index of clinical suspicion is essential.
Management of CST is an emergency and requires immediate hospitalization. Septic CST is treated with broad-spectrum intravenous antibiotics, typically a combination of a third-generation cephalosporin and vancomycin, with antifungal therapy added if indicated. Aseptic CST is managed with anticoagulation, while cases related to fistulas may require angiography and endovascular intervention. Surgical drainage of the primary infectious source, such as sinus or dental abscess, is often necessary. The use of anticoagulation in septic CST remains controversial but may be considered in selected cases. Corticosteroids are reserved for specific indications such as pituitary insufficiency.
Close inpatient monitoring is critical, often in an intensive care setting for severe cases. Follow-up care depends on the underlying cause and includes prolonged antibiotic therapy, monitoring for recurrence, and management of any persistent neurologic deficits. Patients with hypercoagulable states may require long-term anticoagulation.
The prognosis of CST depends on its cause and the timeliness of treatment. Septic CST carries a guarded prognosis, with significant mortality and a high rate of long-term neurologic sequelae among survivors. In contrast, CST associated with fistulas generally has a better outcome if treated appropriately. Complications include permanent vision loss, cranial nerve deficits, intracranial infections such as meningitis or encephalitis, hemorrhagic stroke, and death.
Early recognition and prompt treatment are essential to improving outcomes. Key clinical clues include bilateral orbital signs, cranial nerve involvement, and a history of infection or hypercoagulable risk factors. Even in the presence of inconclusive imaging, CST should be strongly considered when clinical suspicion is high, as delays in treatment can lead to devastating consequences.
0 Comments
